Cortical gene expression after a conditional knockout of 67 kda glutamic acid decarboxylase in parvalbumin neurons

Schizophrenia Bulletin

Volumn 42, Issue 4, 2016, Pages 992-1002

  Georgiev, Danko ^a   Yoshihara, Toru ^a   Kawabata, Rika ^a   Matsubara, Takurou ^a   Tsubomoto, Makoto ^a   Minabe, Yoshio ^a   Lewis, David A ^b   Hashimoto, Takanori ^a,b  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; In situ hybridization; Mouse; Prepulse inhibition; Schizophrenia; Working memory

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; GLUTAMATE DECARBOXYLASE 65; GLUTAMATE DECARBOXYLASE 67; MESSENGER RNA; PARVALBUMIN; PEPTIDES AND PROTEINS; PROTEIN KCNS3; UNCLASSIFIED DRUG; 4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID RECEPTOR; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CORTEX; FEMALE; GENE EXPRESSION; GENE INACTIVATION; GENETIC TRANSCRIPTION; HOMOZYGOSITY; IN SITU HYBRIDIZATION; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; SENSORY GATING; WORKING MEMORY; ANIMAL; ANIMAL BEHAVIOR; C57BL MOUSE; DISEASE MODEL; GENETICS; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; PHYSIOLOGY; PREPULSE INHIBITION; SCHIZOPHRENIA; SHORT TERM MEMORY;

ANIMALS; BEHAVIOR, ANIMAL; CEREBRAL CORTEX; DISEASE MODELS, ANIMAL; FEMALE; GABAERGIC NEURONS; GAMMA-AMINOBUTYRIC ACID; GENE EXPRESSION; GLUTAMATE DECARBOXYLASE; MALE; MEMORY, SHORT-TERM; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PARVALBUMINS; PREPULSE INHIBITION; SCHIZOPHRENIA;

EID: 84979258335     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbw022     Document Type: Article

References (62)

1. Hashimoto T, Volk DW, Eggan SM, et al. Gene expression deficits in a subclass of GABA neurons in the prefrontal cortex of subjects with schizophrenia. J Neurosci. 2003;23:6315-6326.
2. Curley AA, Arion D, Volk DW, et al. Cortical deficits of glutamic acid decarboxylase 67 expression in schizophrenia: clinical, protein, and cell type-specific features. Am J Psychiatry. 2011;168:921-929.
3. Ohnuma T, Augood SJ, Arai H, McKenna PJ, Emson PC. Measurement of GABAergic parameters in the prefrontal cortex in schizophrenia: focus on GABA content, GABA(A) receptor alpha-1 subunit messenger RNA and human GABA transporter-1 (HGAT-1) messenger RNA expression. Neuroscience. 1999;93:441-448.
4. Pierri JN, Chaudry AS, Woo TU, Lewis DA. Alterations in chandelier neuron axon terminals in the prefrontal cortex of schizophrenic subjects. Am J Psychiatry. 1999;156:1709-1719.
5. Glausier JR, Fish KN, Lewis DA. Altered parvalbumin basket cell inputs in the dorsolateral prefrontal cortex of schizophrenia subjects. Mol Psychiatry. 2014;19:30-36.
6. Weickert CS, Ligons DL, Romanczyk T, et al. Reductions in neurotrophin receptor mRNAs in the prefrontal cortex of patients with schizophrenia. Mol Psychiatry. 2005;10:637-650.
7. Hashimoto T, Bergen SE, Nguyen QL, et al. Relationship of brain-derived neurotrophic factor and its receptor TrkB to altered inhibitory prefrontal circuitry in schizophrenia. J Neurosci. 2005;25:372-383.
8. Ray MT, Shannon Weickert C, Webster MJ. Decreased BDNF and TrkB mRNA expression in multiple cortical areas of patients with schizophrenia and mood disorders. Transl Psychiatry. 2014;4:e389.
9. Morris HM, Hashimoto T, Lewis DA. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. Cereb Cortex. 2008;18:1575-1587.
10. Mellios N, Huang HS, Baker SP, et al. Molecular determinants of dysregulated GABAergic gene expression in the prefrontal cortex of subjects with schizophrenia. Biol Psychiatry. 2009;65:1006-1014.
11. Fung SJ, Webster MJ, Sivagnanasundaram S, et al. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. Am J Psychiatry. 2010;167:1479-1488.
12. Akbarian S, Huntsman MM, Kim JJ, et al. GABAA receptor subunit gene expression in human prefrontal cortex: comparison of schizophrenics and controls. Cereb Cortex. 1995;5:550-560.
13. Hashimoto T, Arion D, Unger T, et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia. Mol Psychiatry. 2008;13:147-161.
14. Okaty BW, Miller MN, Sugino K, Hempel CM, Nelson SB. Transcriptional and electrophysiological maturation of neocortical fast-spiking GABAergic interneurons. J Neurosci. 2009;29:7040-7052.
15. Georgiev D, Gonzalez-Burgos G, Kikuchi M, et al. Selective expression of KCNS3 potassium channel alpha-subunit in parvalbumin-containing GABA neurons in the human prefrontal cortex. PLoS One. 2012;7:e43904.
16. Patel AJ, Lazdunski M, Honoré E. Kv2.1/Kv9.3, a novel ATPdependent delayed-rectifier K+ channel in oxygen-sensitive pulmonary artery myocytes. EMBO J. 1997;16:6615-6625.
17. Georgiev D, Arion D, Enwright JF, et al. Lower gene expression for KCNS3 potassium channel subunit in parvalbumincontaining neurons in the prefrontal cortex in schizophrenia. Am J Psychiatry. 2014;171:62-71.
18. Guidotti A, Auta J, Davis JM, et al. Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. Arch Gen Psychiatry. 2000;57:1061-1069.
19. Huang HS, Matevossian A, Whittle C, et al. Prefrontal dysfunction in schizophrenia involves mixed-lineage leukemia 1-regulated histone methylation at GABAergic gene promoters. J Neurosci. 2007;27:11254-11262.
20. Glausier JR, Kimoto S, Fish KN, Lewis DA. Lower glutamic acid decarboxylase 65-kDa isoform messenger RNA and protein levels in the prefrontal cortex in schizoaffective disorder but not schizophrenia. Biol Psychiatry. 2015;77:167-176.
21. Overstreet LS, Westbrook GL. Synapse density regulates independence at unitary inhibitory synapses. J Neurosci. 2003;23:2618-2626.
22. Vreugdenhil M, Jefferys JG, Celio MR, Schwaller B. Parvalbumin-deficiency facilitates repetitive IPSCs and gamma oscillations in the hippocampus. J Neurophysiol. 2003;89:1414-1422.
23. Segal M, Andersen P. Dendritic spines shaped by synaptic activity. Curr Opin Neurobiol. 2000;10:582-586.
24. Yin DM, Sun XD, Bean JC, et al. Regulation of spine formation by ErbB4 in PV-positive interneurons. J Neurosci. 2013;33:19295-19303.
25. Hendry SH, Huntsman MM, Vinuela A, et al. GABAA receptor subunit immunoreactivity in primate visual cortex: distribution in macaques and humans and regulation by visual input in adulthood. J Neurosci. 1994;14:2383-2401.
26. Huang ZJ, Kirkwood A, Pizzorusso T, et al. BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. Cell. 1999;98:739-755.
27. Kingsbury TJ, Murray PD, Bambrick LL, Krueger BK. Ca(2+)-dependent regulation of TrkB expression in neurons. J Biol Chem. 2003;278:40744-40748.
28. Glorioso C, Sabatini M, Unger T, et al. Specificity and timing of neocortical transcriptome changes in response to BDNF gene ablation during embryogenesis or adulthood. Mol Psychiatry. 2006;11:633-648.
29. Pfeffer CK, Xue M, He M, Huang ZJ, Scanziani M. Inhibition of inhibition in visual cortex: the logic of connections between molecularly distinct interneurons. Nat Neurosci. 2013;16:1068-1076.
30. Cottam JC, Smith SL, Häusser M. Target-specific effects of somatostatin-expressing interneurons on neocortical visual processing. J Neurosci. 2013;33:19567-19578.
31. Volk D, Austin M, Pierri J, Sampson A, Lewis D. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons. Am J Psychiatry. 2001;158:256-265.
32. Akbarian S, Kim JJ, Potkin SG, et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Arch Gen Psychiatry. 1995;52:258-266.
33. Volk DW, Austin MC, Pierri JN, Sampson AR, Lewis DA. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. Arch Gen Psychiatry. 2000;57:237-245.
34. Hippenmeyer S, Vrieseling E, Sigrist M, et al. A developmental switch in the response of DRG neurons to ETS transcription factor signaling. PLoS Biol. 2005;3:e159.
35. Obata K, Hirono M, Kume N, et al. GABA and synaptic inhibition of mouse cerebellum lacking glutamate decarboxylase 67. Biochem Biophys Res Commun. 2008;370:429-433.
36. Wisden W, Laurie DJ, Monyer H, Seeburg PH. The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, diencephalon, mesencephalon. J Neurosci. 1992;12:1040-1062.
37. Esclapez M, Tillakaratne NJ, Kaufman DL, Tobin AJ, Houser CR. Comparative localization of two forms of glutamic acid decarboxylase and their mRNAs in rat brain supports the concept of functional differences between the forms. J Neurosci. 1994;14:1834-1855.
38. Curley AA, Eggan SM, Lazarus MS, et al. Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiol Dis. 2013;50:179-186.
39. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. 3rd ed. San Diego, CA: Academic Press; 2008.
40. Behrens MM, Ali SS, Dao DN, et al. Ketamine-induced loss of phenotype of fast-spiking interneurons is mediated by NADPH-oxidase. Science. 2007;318:1645-1647.
41. Belforte JE, Zsiros V, Sklar ER, et al. Postnatal NMDA receptor ablation in corticolimbic interneurons confers schizophrenia-like phenotypes. Nat Neurosci. 2010;13:76-83.
42. Coyle JT. Glutamate and schizophrenia: beyond the dopamine hypothesis. Cell Mol Neurobiol. 2006;26:365-384.
43. Luo Y, Lathia J, Mughal M, Mattson MP. SDF1alpha/CXCR4 signaling, via ERKs and the transcription factor Egr1, induces expression of a 67-kDa form of glutamic acid decarboxylase in embryonic hippocampal neurons. J Biol Chem. 2008;283:24789-24800.
44. Patz S, Grabert J, Gorba T, Wirth MJ, Wahle P. Parvalbumin expression in visual cortical interneurons depends on neuronal activity and TrkB ligands during an Early period of postnatal development. Cereb Cortex. 2004;14:342-351.
45. Homayoun H, Moghaddam B. NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons. J Neurosci. 2007;27:11496-11500.
46. Rotaru DC, Yoshino H, Lewis DA, Ermentrout GB, Gonzalez-Burgos G. Glutamate receptor subtypes mediating synaptic activation of prefrontal cortex neurons: relevance for schizophrenia. J Neurosci. 2011;31:142-156.
47. Garey LJ, Ong WY, Patel TS, et al. Reduced dendritic spine density on cerebral cortical pyramidal neurons in schizophrenia. J Neurol Neurosurg Psychiatry. 1998;65:446-453.
48. Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65-73.
49. Fitzgerald ML, Lupica CR, Pickel VM. Decreased parvalbumin immunoreactivity in the cortex and striatum of mice lacking the CB1 receptor. Synapse. 2011;65:827-831.
50. Lazarus MS, Krishnan K, Huang ZJ. GAD67 deficiency in parvalbumin interneurons produces deficits in inhibitory transmission and network disinhibition in mouse prefrontal cortex. Cereb Cortex. 2015;25:1290-1296.
51. Deidda G, Allegra M, Cerri C, et al. Early depolarizing GABA controls critical-period plasticity in the rat visual cortex. Nat Neurosci. 2015;18:87-96.
52. Lee KY, Royston SE, Vest MO, et al. N-methyl-D-aspartate receptors mediate activity-dependent down-regulation of potassium channel genes during the expression of homeostatic intrinsic plasticity. Mol Brain. 2015;8:4.
53. Fujihara K, Miwa H, Kakizaki T, et al. Glutamate decarboxylase 67 deficiency in a subset of GABAergic neurons induces schizophrenia-related phenotypes. Neuropsychopharmacology. 2015;40:2475-2486.
54. Richetto J, Calabrese F, Riva MA, Meyer U. Prenatal immune activation induces maturation-dependent alterations in the prefrontal GABAergic transcriptome. Schizophr Bull. 2014;40:351-361.
55. Cabungcal JH, Counotte DS, Lewis EM, et al. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron. 2014;83:1073-1084.
56. Kuhlman SJ, Huang ZJ. High-resolution labeling and functional manipulation of specific neuron types in mouse brain by Cre-activated viral gene expression. PLoS One. 2008;3:e2005.
57. Garbett KA, Horváth S, Ebert PJ, et al. Novel animal models for studying complex brain disorders: BAC-driven miRNAmediated in vivo silencing of gene expression. Mol Psychiatry. 2010;15:987-995.
58. Brown JA, Horváth S, Garbett KA, et al. The role of cannabinoid 1 receptor expressing interneurons in behavior. Neurobiol Dis. 2014;63:210-221.
59. Schmidt MJ, Horvath S, Ebert P, et al. Modulation of behavioral networks by selective interneuronal inactivation. Mol Psychiatry. 2014;19:580-587.
60. Brown JA, Ramikie TS, Schmidt MJ, et al. Inhibition of parvalbumin-expressing interneurons results in complex behavioral changes. Mol Psychiatry. 2015;20:1499-1507.
61. Marty S, Onténiente B. The expression pattern of somatostatin and calretinin by postnatal hippocampal interneurons is regulated by activity-dependent and-independent determinants. Neuroscience. 1997;80:79-88.
62. Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience. 2013;251:90-107.